Opaleye Management Inc. - Insider Trading & Ownership

Entity: Company
Location: One Boston Place, Suite 2600, Boston, MA
Summary: The estimated value of insider holdings of Opaleye Management Inc. is at least $202M dollars as of March 20, 2025. Opaleye Management Inc. is the 10%+ Owner of HARROW, INC. and owns shares of HARROW, INC. (HROW) stock worth about $117M. Opaleye Management Inc. is the 10%+ Owner of SANUWAVE Health, Inc. and owns shares of SANUWAVE Health, Inc. (SNWV) stock worth about $24.4M. Opaleye Management Inc. is the 10%+ Owner of CODEXIS, INC. and owns shares of CODEXIS, INC. (CDXS) stock worth about $23.3M. Opaleye Management Inc. is the 10%+ Owner of Eton Pharmaceuticals, Inc. and owns shares of Eton Pharmaceuticals, Inc. (ETON) stock worth about $22.1M. Opaleye Management Inc. is the Former 10% Owner. of TELA Bio, Inc. and owns shares of TELA Bio, Inc. (TELA) stock worth about $11.7M. Opaleye Management Inc. is the 10%+ Owner of Protara Therapeutics, Inc. and owns shares of Protara Therapeutics, Inc. (TARA) stock worth about $3.4M.
All Insider Reports: All Insider Reports

Ownership of Opaleye Management Inc.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
HROW, HROWL	HARROW, INC.	10%+ Owner	$117M	+$355K	+0.3%	Mar 18, 2025
SNWV	SANUWAVE Health, Inc.	10%+ Owner	$24.4M			Oct 30, 2024
CDXS	CODEXIS, INC.	10%+ Owner	$23.3M	+$5.75M	+32.8%	Mar 13, 2025
ETON	Eton Pharmaceuticals, Inc.	10%+ Owner	$22.1M	+$585K	+2.72%	Oct 23, 2024
TELA	TELA Bio, Inc.	Former 10% Owner.	$11.7M			Apr 20, 2023
TARA	Protara Therapeutics, Inc.	10%+ Owner	$3.4M	-$1.75M	-34%	Sep 11, 2024
TCON	Tracon Pharmaceuticals, Inc.	10%+ Owner				Nov 10, 2023

Showing 1 to 7 of 7 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.